Pharmaceuticals India News
  • Home
  • Brands
    • Alkem
    • Apollo Hospital
    • Aurobindo Pharma
    • Biocon
    • Cipla
    • Divi’s Laboratories
    • Dr Reddy’s
    • Fortis
    • Glenmark
    • Lupin
    • Mankind Pharma
    • Natco
    • Pfizer
    • Piramal Pharma
    • Sun Pharma
    • Torrent Pharma
    • Zydus
Select Page

Glenmark Pharmaceuticals Sees Significant Profit Increase in March 2025 Despite Elevated Interest Expenses – MarketsMojo

by Team Small News | May 24, 2025 | Glenmark, Pharma

Glenmark Pharmaceuticals has announced its financial results for the fourth quarter and full year ended March 2025, highlighting a solid profit growth despite increasing interest costs. The company’s performance was driven by robust sales across its key markets...

PGIMER’s Transfusion Medicine Department Collects 117 Units of Blood, Sets Up Next Donation Camp at Glenmark Pharmaceuticals, Nalagarh on May 15

by Team Small News | May 15, 2025 | Glenmark, Pharma

The Department of Transfusion Medicine at PGIMER, Chandigarh, recently conducted two blood donation camps in the city, with the goal of ensuring an adequate blood supply for patients in need. The first camp was held on May 14, 2025, at the Community Center in...

NIVEA India names Akshay Kawale as new Business Unit Head – Derma

by Team Small News | May 14, 2025 | Glenmark, Pharma

NIVEA India has appointed Akshay Kawale as the Business Unit Head of its Derma division, effective April 3, 2025. Kawale brings 16 years of experience in the industry, having worked with prominent organizations such as Glenmark Pharmaceuticals, Abbott, GSK, and...

Glenmark Pharma’s oncology treatment gets expedited review with FDA’s ‘fast track’ designation

by Team Small News | May 6, 2025 | Glenmark, Pharma

Glenmark Pharmaceuticals’ subsidiary, Ichnos Glenmark Innovation (IGI), has received a “fast track” designation from the United States Food and Drug Administration (USFDA) for its investigational therapy, ISB 2001. This therapy is intended for the...

Glenmark’s UK approval of Dapagliflozin overturned on appeal as Teva prepared to enter the market

by Team Small News | Apr 30, 2025 | Glenmark, Pharma

The UK Court of Appeal has overturned an earlier decision, granting AstraZeneca’s request for an injunction against Glenmark Pharmaceuticals’ generic version of the diabetes treatment Forxiga (dapagliflozin). This decision comes as a significant setback...
Indian pharmaceutical companies Sun Pharma, Zydus, and Glenmark have issued recalls of their products in the US due to manufacturing concerns.

Indian pharmaceutical companies Sun Pharma, Zydus, and Glenmark have issued recalls of their products in the US due to manufacturing concerns.

by Team Small News | Apr 15, 2025 | Glenmark, Pharma, Sun Pharma, Zydus

Three major Indian pharmaceutical companies, Sun Pharma, Zydus, and Glenmark, have issued recalls of their products in the United States due to manufacturing issues. The recalls were announced by the US Food and Drug Administration (FDA) and cover a range of products,...
« Older Entries

_________

Pharna Brands

  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma
  • Torrent Pharma
  • Zydus
  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Torrent Pharma
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Zydus
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma

    Designed by Elegant Themes | Powered by WordPress